+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Prostate Cancer Therapeutics Market - Product Thumbnail Image

Prostate Cancer Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Alport Syndrome Market - Global Forecast 2026-2032 - Product Thumbnail Image

Alport Syndrome Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
From
From
Emphysema Treatment Market Report 2026 - Product Thumbnail Image

Emphysema Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Angiotensin Receptor Blockers (ARBs) Market Report 2026 - Product Thumbnail Image

Angiotensin Receptor Blockers (ARBs) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Japan Healthcare Outlook Report, 2022 - Product Thumbnail Image

Japan Healthcare Outlook Report, 2022

  • Report
  • January 2022
  • 60 Pages
  • Japan
From
Cystitis- Pipeline Insight, 2025 - Product Thumbnail Image

Cystitis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Scleroderma Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Scleroderma Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Loading Indicator